Literature DB >> 8369134

Target dose versus extratarget dose in stereotactic radiosurgery.

I Lax1.   

Abstract

In radiosurgery the dose in the periphery of the target is generally about 50-70% of the maximum dose. This type of dose distribution may be expected to be beneficial when tumours containing anoxic, more radioresistant, cells are treated. However, the impact of a high maximum dose in the target on the dose outside the target is of importance for the risk of complications. Dose distributions have been calculated for different beam geometries applicable to radiosurgery by integration of the dose from a continuum of beams. The dose distributions were calculated for beams of different diameters, and the distributions were weighted to give the same dose in the periphery of the target. With a 4 pi beam geometry it is shown that the maximum dose in the central parts of the target can be increased by a factor of 2, by using beams with smaller diameters, at the cost of a marginal increase of the dose outside the target. The average dose in the normal tissue outside increases from 29.8% with 18 mm beams to 34.1% with 14 mm beams, while the average dose within the target increases from 100 to 158%. In radiosurgery of tumours a high maximum dose in the target may give a therapeutic gain.

Entities:  

Mesh:

Year:  1993        PMID: 8369134     DOI: 10.3109/02841869309093624

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  6 in total

1.  Dynamic conformal arc cranial stereotactic radiosurgery: implications of multileaf collimator margin on dose-volume metrics.

Authors:  J A Tanyi; E J Doss; C M Kato; D L Monaco; L ZMeng; Y Chen; C D Kubicky; C M Marquez; M Fuss
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

2.  A technique for stereotactic radiosurgery treatment planning with helical tomotherapy.

Authors:  Emilie T Soisson; Peter W Hoban; Thomas Kammeyer; Jeffrey M Kapatoes; David C Westerly; Amar Basavatia; Wolfgang A Tomé
Journal:  Med Dosim       Date:  2011       Impact factor: 1.482

3.  A retrospective study of SBRT of metastases in patients with primary sarcoma.

Authors:  Christina Linder Stragliotto; Kristin Karlsson; Ingmar Lax; Eva Rutkowska; Jonas Bergh; Hans Strander; Henric Blomgren; Signe Friesland
Journal:  Med Oncol       Date:  2012-07-20       Impact factor: 3.064

4.  Radiation treatment planning with embedded dose escalation.

Authors:  William T Hrinivich; Todd R McNutt; Jeffrey J Meyer
Journal:  Radiat Oncol       Date:  2019-08-14       Impact factor: 3.481

Review 5.  Image guidance: past and future of radiotherapy.

Authors:  H Herrmann; Y Seppenwoolde; D Georg; J Widder
Journal:  Radiologe       Date:  2019-12       Impact factor: 0.635

Review 6.  The impact of technology on the changing practice of lung SBRT.

Authors:  Marianne Camille Aznar; Samantha Warren; Mischa Hoogeman; Mirjana Josipovic
Journal:  Phys Med       Date:  2018-01-10       Impact factor: 2.685

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.